Weiss Ratings Reiterates “Sell (D-)” Rating for Arcadia Biosciences (NASDAQ:RKDA)

Arcadia Biosciences (NASDAQ:RKDA)‘s stock had its “sell (d-)” rating reiterated by research analysts at Weiss Ratings in a research report issued to clients and investors on Tuesday,Weiss Ratings reports.

Arcadia Biosciences Trading Up 47.7%

Shares of RKDA opened at $5.45 on Tuesday. The company has a market capitalization of $7.45 million, a PE ratio of -1.27 and a beta of 0.53. Arcadia Biosciences has a 12 month low of $2.53 and a 12 month high of $10.31. The stock’s 50-day moving average price is $3.80 and its two-hundred day moving average price is $3.98.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Thursday, August 14th. The basic materials company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.79) by $0.81. The firm had revenue of $1.46 million for the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative return on equity of 34.75% and a negative net margin of 139.36%.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.